Literature for peptidase M10.009: matrix metallopeptidase-12

(References are filtered for relevance to Target. To remove the filter click here. See explanation.)

2018
1. Chelluboina,B., Nalamolu,K.R., Klopfenstein,J.D., Pinson,D.M., Wang,D.Z., Vemuganti,R. and Veeravalli,K.K.
   MMP-12, a promising therapeutic target for neurological diseases
   Mol Neurobiol55, 1405-1409. PubMed  Europe PubMed DOI  T  V
2010
2. Mukhopadhyay,S., Sypek,J., Tavendale,R., Gartner,U., Winter,J., Li,W., Page,K., Fleming,M., Brady,J., O'Toole,M., Macgregor,D.F., Goldman,S., Tam,S., Abraham,W., Williams,C., Miller,D.K. and Palmer,C.N.
   Matrix metalloproteinase-12 is a therapeutic target for asthma in children and young adults
   J Allergy Clin Immunol126, 70-76. PubMed  Europe PubMed DOI  T
2009
3. Crouser,E.D., Culver,D.A., Knox,K.S., Julian,M.W., Shao,G., Abraham,S., Liyanarachchi,S., Macre,J.E., Wewers,M.D., Gavrilin,M.A., Ross,P., Abbas,A. and Eng,C.
   Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis
   Am J Respir Crit Care Med179, 929-938. PubMed  Europe PubMed DOI  T
4. Lagente,V., Le Quement,C. and Boichot,E.
   Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases
   Expert Opin Ther Targets13, 287-295. PubMed  Europe PubMed DOI  T